Baric Transcribed Interview (Redacted) — page 94
of 155 pages
← p.93 p.95 → · this page in the original PDF · package
DC.Scheduling@LexitasLegal.com
be then to find sarbecoviruses. If we found the
sarbecovirus with a furin cleavage site it would be dropped
into a pseudovirus, and its biological characteristics
evaluated by the Chinese. They would remove the furin
cleavage site. They would introduce changes into the
receptor binding domain and look in the context of those
pseudotypes, which is the safe system, to ask questions
about what the role of those mutations were in tropism and
entry of viruses in receptor usage.
Following gleaning that data, we would then use a
zoonotic sarbecovirus as a receptacle to drop the spike
genes of some of these viruses, and if we found one with
full-on furin site we would put it in there and evaluate
its biology. We would also remove that furin cleavage site
and ask what the effect was on pathogenesis in replication.
So it's a loss-of-function first.
At the end of that there was speculation that if the
furin cleavage site looked like it was having effect on
replication of pathogenesis we would consider putting it
into a gain-of-function scenario where we would drop it
into a null backbone. So that's how the experiment was
written.
MS. SALAZAR: And who was going to be doing that work?
DR. BARIC: That part would be done by me.
MS. SALAZAR: Okay.
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/baric_ti/94
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| baric_ti:utt:00829 | 2026-04-10 | transcript segment | 92–94 |
| baric_ti:utt:00830 | 2026-04-10 | transcript segment | 94 |
| baric_ti:utt:00831 | 2026-04-10 | transcript segment | 94 |
| baric_ti:utt:00832 | 2026-04-10 | transcript segment | 94–95 |